Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Creative Medical Technology Holdings, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 13 | 9 | −4 |
| Shares | 106.1K | 69.4K | −36.8K (−34.6%) |
| Value | $551.9K | $267.0K | −$284.9K (−51.6%) |
New holders (1)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TD Waterhouse Canada Inc. | 1 | $4 | 0.00% |
Sold out (5)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Virtu Financial LLC | 16,374 | $85.0K |
| HRT Financial LP | 13,194 | $68.0K |
| Omers Administration Corp | 11,000 | $57.3K |
| UBS Group AG | 3,064 | $16.0K |
| Wells Fargo & Company | 11 | $57 |